Contract Services For Formulation, Analysis, Stabilization and Delivery of Biotechnology-Based Products

For years, recombinant DNA technology has led to protein-based therapies that have revolutionized the pharmaceutical industry. Yet, the effort required to turn promising candidates into marketed products is enormous. Legacy BioDesign was established to provide the highest quality support for formulation and assay development. Unlike many contract research organizations (CROs), Legacy seeks to establish a strong rapport with our clients, so that they can be assured that the work is being done accurately and efficiently. At Legacy, trust, quality and reliability are as important as our technical skills. Using an established network of laboratories (including GLP/GMP facilities), Legacy will partner with your organization to develop formulations and assays in an efficient and responsible fashion. Read more ...